Intraindividual, randomized comparison of the macrocyclic contrast agents gadobutrol and gadoterate meglumine in breast magnetic resonance imaging.
Saved in:
| Title: | Intraindividual, randomized comparison of the macrocyclic contrast agents gadobutrol and gadoterate meglumine in breast magnetic resonance imaging. |
|---|---|
| Authors: | Fallenberg, Eva1 eva.fallenberg@charite.de, Renz, Diane1, Karle, Bettina2, Schwenke, Carsten3, Ingod-Heppner, Barbara4, Reles, Angela5, Engelken, Florian6, Huppertz, Alexander7, Hamm, Bernd1, Taupitz, Matthias7 |
| Source: | European Radiology. Mar2015, Vol. 25 Issue 3, p837-849. 13p. |
| Subjects: | Magnetic resonance imaging, Breast cancer diagnosis, Tissue wounds, Diagnostic imaging research, Medical imaging systems |
| Abstract: | Objectives: To compare intraindividually two macrocyclic contrast agents - gadobutrol and gadoterate meglumine (Gd-DOTA) - for dynamic and quantitative assessment of relative enhancement (RE) in benign and malignant breast lesions. Methods: This was an ethically approved, prospective, single-centre, randomized, crossover study in 52 women with suspected breast lesions referred for magnetic resonance imaging (MRI). Each patient underwent one examination with gadobutrol and one with Gd-DOTA (0.1 mmol/kg BW) on a 1.5 T system 1 - 7 days apart. Dynamic, T1-weighted, 3D gradient echo sequences were acquired under identical conditions. Quantitative evaluation with at least three regions of interest (ROI) per lesion was performed. Primary endpoint was RE during the initial postcontrast phase after the first and second dynamic acquisition, and peak RE. All lesions were histologically proven; differences between the examinations were evaluated. Results: Forty-five patients with a total of 11 benign and 34 malignant lesions were assessed. Mean RE was significantly higher for gadobutrol than Gd-DOTA ( p < 0.0001). Gadobutrol showed significantly less washout (64.4 %) than Gd-DOTA (75.4 %) in malignant lesions ( p = 0.048) Conclusions: Gadobutrol has higher RE values compared with Gd-DOTA, whereas Gd-DOTA shows more marked washout in malignant lesions. This might improve the detection of breast lesions and influence the specificity of breast MRI-imaging. Key Points: • Contrast agents differ in terms of peak enhancement and postinitial contrast behaviour. • Gadobutrol results in greater peak RE in lesions, likely due to relaxivity. • Gd-DOTA shows more pronounced washout in postinitial contrast behaviour of malignant lesions. • Further investigations of the differences among GD-CM may improve sensitivity and specificity. [ABSTRACT FROM AUTHOR] |
| Copyright of European Radiology is the property of Springer Nature and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) | |
| Database: | Engineering Source |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: egs DbLabel: Engineering Source An: 100989890 AccessLevel: 6 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Intraindividual, randomized comparison of the macrocyclic contrast agents gadobutrol and gadoterate meglumine in breast magnetic resonance imaging. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Fallenberg%2C+Eva%22">Fallenberg, Eva</searchLink><relatesTo>1</relatesTo><i> eva.fallenberg@charite.de</i><br /><searchLink fieldCode="AR" term="%22Renz%2C+Diane%22">Renz, Diane</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Karle%2C+Bettina%22">Karle, Bettina</searchLink><relatesTo>2</relatesTo><br /><searchLink fieldCode="AR" term="%22Schwenke%2C+Carsten%22">Schwenke, Carsten</searchLink><relatesTo>3</relatesTo><br /><searchLink fieldCode="AR" term="%22Ingod-Heppner%2C+Barbara%22">Ingod-Heppner, Barbara</searchLink><relatesTo>4</relatesTo><br /><searchLink fieldCode="AR" term="%22Reles%2C+Angela%22">Reles, Angela</searchLink><relatesTo>5</relatesTo><br /><searchLink fieldCode="AR" term="%22Engelken%2C+Florian%22">Engelken, Florian</searchLink><relatesTo>6</relatesTo><br /><searchLink fieldCode="AR" term="%22Huppertz%2C+Alexander%22">Huppertz, Alexander</searchLink><relatesTo>7</relatesTo><br /><searchLink fieldCode="AR" term="%22Hamm%2C+Bernd%22">Hamm, Bernd</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Taupitz%2C+Matthias%22">Taupitz, Matthias</searchLink><relatesTo>7</relatesTo> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22European+Radiology%22">European Radiology</searchLink>. Mar2015, Vol. 25 Issue 3, p837-849. 13p. – Name: Subject Label: Subjects Group: Su Data: <searchLink fieldCode="DE" term="%22Magnetic+resonance+imaging%22">Magnetic resonance imaging</searchLink><br /><searchLink fieldCode="DE" term="%22Breast+cancer+diagnosis%22">Breast cancer diagnosis</searchLink><br /><searchLink fieldCode="DE" term="%22Tissue+wounds%22">Tissue wounds</searchLink><br /><searchLink fieldCode="DE" term="%22Diagnostic+imaging+research%22">Diagnostic imaging research</searchLink><br /><searchLink fieldCode="DE" term="%22Medical+imaging+systems%22">Medical imaging systems</searchLink> – Name: Abstract Label: Abstract Group: Ab Data: Objectives: To compare intraindividually two macrocyclic contrast agents - gadobutrol and gadoterate meglumine (Gd-DOTA) - for dynamic and quantitative assessment of relative enhancement (RE) in benign and malignant breast lesions. Methods: This was an ethically approved, prospective, single-centre, randomized, crossover study in 52 women with suspected breast lesions referred for magnetic resonance imaging (MRI). Each patient underwent one examination with gadobutrol and one with Gd-DOTA (0.1 mmol/kg BW) on a 1.5 T system 1 - 7 days apart. Dynamic, T1-weighted, 3D gradient echo sequences were acquired under identical conditions. Quantitative evaluation with at least three regions of interest (ROI) per lesion was performed. Primary endpoint was RE during the initial postcontrast phase after the first and second dynamic acquisition, and peak RE. All lesions were histologically proven; differences between the examinations were evaluated. Results: Forty-five patients with a total of 11 benign and 34 malignant lesions were assessed. Mean RE was significantly higher for gadobutrol than Gd-DOTA ( p < 0.0001). Gadobutrol showed significantly less washout (64.4 %) than Gd-DOTA (75.4 %) in malignant lesions ( p = 0.048) Conclusions: Gadobutrol has higher RE values compared with Gd-DOTA, whereas Gd-DOTA shows more marked washout in malignant lesions. This might improve the detection of breast lesions and influence the specificity of breast MRI-imaging. Key Points: • Contrast agents differ in terms of peak enhancement and postinitial contrast behaviour. • Gadobutrol results in greater peak RE in lesions, likely due to relaxivity. • Gd-DOTA shows more pronounced washout in postinitial contrast behaviour of malignant lesions. • Further investigations of the differences among GD-CM may improve sensitivity and specificity. [ABSTRACT FROM AUTHOR] – Name: AbstractSuppliedCopyright Label: Group: Ab Data: <i>Copyright of European Radiology is the property of Springer Nature and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.) |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=egs&AN=100989890 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s00330-014-3426-0 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 13 StartPage: 837 Subjects: – SubjectFull: Magnetic resonance imaging Type: general – SubjectFull: Breast cancer diagnosis Type: general – SubjectFull: Tissue wounds Type: general – SubjectFull: Diagnostic imaging research Type: general – SubjectFull: Medical imaging systems Type: general Titles: – TitleFull: Intraindividual, randomized comparison of the macrocyclic contrast agents gadobutrol and gadoterate meglumine in breast magnetic resonance imaging. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Fallenberg, Eva – PersonEntity: Name: NameFull: Renz, Diane – PersonEntity: Name: NameFull: Karle, Bettina – PersonEntity: Name: NameFull: Schwenke, Carsten – PersonEntity: Name: NameFull: Ingod-Heppner, Barbara – PersonEntity: Name: NameFull: Reles, Angela – PersonEntity: Name: NameFull: Engelken, Florian – PersonEntity: Name: NameFull: Huppertz, Alexander – PersonEntity: Name: NameFull: Hamm, Bernd – PersonEntity: Name: NameFull: Taupitz, Matthias IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 03 Text: Mar2015 Type: published Y: 2015 Identifiers: – Type: issn-print Value: 09387994 Numbering: – Type: volume Value: 25 – Type: issue Value: 3 Titles: – TitleFull: European Radiology Type: main |
| ResultId | 1 |